USA
A pharmaceutical company is seeking a Contract Research Organization (CRO) in the USA to manage full-scale clinical trial operations. The ideal CRO must demonstrate extensive experience in clinical monitoring, protocol compliance, adverse event tracking, and patient recruitment with proven capabilities in managing complex, multi-phase trials. Strong credentials include FDA and IRB regulatory compliance, GLP/GCP certification, and robust data management with AI-enabled and decentralized trial platforms.
Italy
A leading research institute in Italy is seeking a Pharmaceutical Company for strategic research collaborations and commercial partnerships. The ideal pharma partner must demonstrate proven expertise in drug discovery and development, compliance with EMA and AIFA regulations, and a strong commitment to ethical standards in clinical trials and patient safety. Essential credentials include a history of successful partnerships with academia, robust R&D capabilities, and the ability to support translational research from bench to bedside.
United Kindom
A pharmaceutical company is seeking a Clinical Research Site in the UK to conduct clinical trials across multiple therapeutic areas. The preferred site must demonstrate: Robust experience in Phase I-IV clinical trials, comprehensive MHRA and NHS Research Ethics Committee (REC) approvals, GCP (Good Clinical Practice) accreditation. Access to a diverse patient population, state-of-the-art facilities, and dedicated clinical trial coordinators. Established infrastructure for data management, pharmacovigilance, and adverse event reporting. Strong relationships with local healthcare providers and the ability to support decentralized or hybrid trial models.
Switzerland
A leading pharmaceutical company in Switzerland is seeking API suppliers and manufacturers for joint development of new active pharmaceutical ingredients. The ideal partners must have demonstrated GMP-certified manufacturing facilities compliant with Swissmedic, EMA, and ICH Q7 guidelines, along with a valid Swiss establishment license for therapeutic products. They should provide transparent and regularly audited documentation, including GMP certificates, audit reports, and Site Master Files, ensuring consistent quality and regulatory compliance.
